MP Healthcare Venture Management
Home About Us Portfolio News Contact
HomeAbout UsPortfolioNewsContact
MP Healthcare Venture Management
Korro Bio Completes $116M Series B Financing to Expand the Frontier of Genetic Medicine through its Pipeline of RNA Editing Programs
Mari YoshiokaJanuary 5, 2022
Facebook0 Twitter LinkedIn0 Reddit 0 Likes
Previous

F-star Therapeutics Announces Merck KGaA, Darmstadt, Germany Exercises a Fourth Licensing Option in Immuno-Oncology Collaboration

Mari YoshiokaJanuary 5, 2022
Next

LiberoThera Secures 300 Million JPY Financing Agreement with Taiho Ventures

Mari YoshiokaAugust 5, 2021

© 2010-2019 MP Healthcare Venture Management, Inc.
All Rights Reserved.

Privacy Policy | Terms of Use

About UsPortfolioNews Contact